Key facts
- Soleus Capital Master Fund, L.P. filed SCHEDULE 13G for NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR).
- Disclosed ownership: 5%.
- Date of event: 31 Mar 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. | 5% | 5,521,414 | 0 | 5,521,414 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital, LLC | 5% | 5,521,414 | 0 | 5,521,414 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Group, LLC | 5% | 5,521,414 | 0 | 5,521,414 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Management, L.P. | 5% | 5,521,414 | 0 | 5,521,414 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus GP, LLC | 5% | 5,521,414 | 0 | 5,521,414 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Guy Levy | 5% | 5,521,414 | 0 | 5,521,414 | /s/ Guy Levy | Guy Levy/Managing Member |
CIK / CUSIP context first